Understanding the relationship between germline and tumour genetics is important in patients where early-onset familial breast cancer or differences in drug response and survival outcome cannot be explained by mutations in the major tumour suppressor genes, BRCA1 and BRCA2 [1,2,3]. This evidence concerns the gene BRCA1 and breast carcinoma.